| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Adverum Biotechnologies, Inc. | Chief Technology Officer | Common Stock | 150,000 | $232,290 | $1.55 | 06 Aug 2021 | Direct |
| Adverum Biotechnologies, Inc. | Chief Technology Officer | Stock Option (Right to Buy) | 120,000 | 06 Aug 2021 | Direct | ||
| Nkarta, Inc. | Director | Stock Option (right to buy) | 46,000 | 05 Jun 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| NKTX | Nkarta, Inc. | 05 Jun 2025 | 1 | $0 | 4 | Director | 09 Jun 2025, 16:04 |
| NKTX | Nkarta, Inc. | 13 Jun 2024 | 1 | $0 | 4 | Director | 14 Jun 2024, 16:07 |
| NKTX | Nkarta, Inc. | 07 Jun 2023 | 1 | $0 | 4 | Director | 09 Jun 2023, 16:08 |
| NKTX | Nkarta, Inc. | 08 Jun 2022 | 1 | $0 | 4 | Director | 10 Jun 2022, 16:12 |
| NKTX | Nkarta, Inc. | 28 Mar 2022 | 1 | $0 | 4 | Director | 29 Mar 2022, 16:12 |
| NKTX | Nkarta, Inc. | 28 Mar 2022 | 0 | $0 | 3 | Director | 29 Mar 2022, 16:09 |
| ADVM | Adverum Biotechnologies, Inc. | 06 Aug 2021 | 2 | $0 | 4 | Chief Technology Officer | 10 Aug 2021, 21:25 |